
News from psychedelicalpha.com
We’ve assigned a media bias rating of unknown to psychedelicalpha.com. You can read more about our methodology here.
If you want to know if psychedelicalpha.com is credible or reliable, look no further. We rank psychedelicalpha.com as Unknown factuality. Find out more about our methodology here.
Information about psychedelicalpha.com
Where is psychedelicalpha.com located?psychedelicalpha.com's WebsiteMedia Bias Ratings
Do you diasgree?
Edit bias
Learn more about Media Bias Ratings.
Factuality
Learn more about Factuality Ratings
Reveal Factuality Ratings by upgrading to a Premium account.
Tap Upgrade to explore subscription options to meet all your reading needs.
Ownership
Learn more about Ownership categories
Reveal Ownership Data by upgrading to a Vantage account.
Tap Upgrade to explore subscription options to meet all your reading needs.
Top psychedelicalpha.com News

InnovationDENVER (KDVR) — A new era in mental health care begins Thursday as Denver is expected to open its application portal for psychedelic healing centers, part of Colorado’s regulated natural medicine program. The move follows the passage of state legislation establishing a framework for psilocybin therapy — a psychedelic compound found in certain mushrooms — for approved mental health treatment. Licensed facilities in cities like Golden are preparin…See the Story
Applications Open Soon for Psychedelic Healing Centers in Denver
Coverage: 7 sources

Psychedelic DrugsWhile positive, results from a late-stage clinical trial appear to be raising questions about how useful the company’s version of psilocybin could be as a depression treatment.See the Story
Compass Pathways Stock Slumps After Positive Late-Stage Trial Results ...
100% Center coverage: 5 sources
That Time A$AP Rocky Took LSD with a Psychedelic Scientist
Pα+ Psychedelic Bulletin #202: Psychedelics Access ‘Within 12 Months’, RFK Jr. Says; Psychedelics in Washington; Lykos’ New CEO, CMO; New Zealand’s First Psilocybin Prescriber; Judge Recommends Schedule I Placement for DOI and DOC - Psychedelic Alpha
Emyria Wins Major Insurer Backing for MDMA-Assisted Therapy
100% Right coverage: 1 sources
May 2025 Psychedelic Patent Update: Gilgamesh Broadens Moat Around Lead Candidate Following Positive Phase 2a Readout; Lykos Publishes Further Continuation Applications; Reconnect Joins Crowded 5-MeO-DMT Patent Landscape - Psychedelic Alpha
Texas Invests $50 Million in Ibogaine Research for Addiction Treatment, Advocates Still Eye Tri-State
72% Center coverage: 18 sources
Pα+ Psychedelic Bulletin #200: Can Czechia Deliver on Psilocybin Access? A Closer Look at ‘atai Beckley’; Q1’25 Psychedelic Lobbying Update; Catching Up with the Class of Bulletin #100 - Psychedelic Alpha
atai Life Sciences and Beckley Psytech to Combine Creating a Global Leader in Psychedelic ...
100% Center coverage: 4 sources